Evoke Pharma Inc
EVOKDrugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Metoclopramide Nasal Spray | Phase 3 | Diabetic Gastroparesis | - | - |
metoclopramide | Phase 2 | Gastroparesis | - | - |
Frequently asked questions
What is in Evoke Pharma Inc's drug pipeline?→
CatalystAlert tracks 2 drug candidates in Evoke Pharma Inc's (EVOK) pipeline across Phase 3, Phase 2. Its lead program is Metoclopramide Nasal Spray (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Evoke Pharma Inc's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Evoke Pharma Inc (EVOK) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track EVOK biotech catalysts?→
Add EVOK to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Evoke Pharma Inc's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.